NIH | National Cancer Institute | NCI Wiki  

Date

Attendees

Committee MemberPresentAbsent
Kuffel, Gina (NIH/NCI) [C]
X

Musk, Philip (NIH/NCI) [C]

X
Warren Kibbe
X
Kim, Erika (NIH/NCI) [E]


Gregory Tawa
X
William Hendriks
X
Matthew Breen
X
Roel Verhaak



Goals

  • Review, discuss, and prioritize ICDC study submission proposals

Outstanding Action items

  • Matthew & Warren to write an email request to Toby pertaining to formalization of a business plan for ICDC.
  • Musk, Philip (NIH/NCI) [C] to brush up on Nanostring documentation.

Agenda

Discussion ItemWhoNotes
New data submission request

Kuffel, Gina (NIH/NCI) [C] 

Data submission recommended by DGAB to the Senior Advisory Committee

Kuffel, Gina (NIH/NCI) [C] 

  • "Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma" 
  • Data Submission Folder: OSA-Normal
PRECINCT Data Request Submission: Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases

All

  • PRECINCT SharePoint submission folder
  • PRECINCT Publication
  • Recently met with UC Davis team to demo the ICDC and discuss next steps for ingesting additional data.
Review of other Modiano publications: Other Modiano Publication Considerations.xlsx

Kuffel, Gina (NIH/NCI) [C]

Study Updates

Musk, Philip (NIH/NCI) [C]

  • TCL01
    • Study identifier changed to TCL01 (Tumor Cell Line)
    • Testing completed
    • Pending release record available on production
    • 6 study files being assembled
  • PRECINCT
    • Program now available on lower tier (dev environment)
    • Study record is in place
  • PANCAN01 (15 TB Re-analysis)
    • Data is already in a ICDC S3 bucket
    • Template-driven study onboarding initiated
    • One study will be onboarded at a time

Minutes (Not Verbatim)

The meeting was cancelled and an email was sent instead to initiate a review of the newest data submission request.

Action items